Search results
Results from the WOW.Com Content Network
Oxiracetam (developmental code name ISF 2522) is a nootropic drug of the racetam family and a very mild stimulant. [1] [2] Several studies suggest that the substance is safe even when high doses are consumed for a long period of time. [3] [4] [5] However, the mechanism of action of the racetam drug family is still a
2-Pyrrolidone Piracetam. Racetams, also sometimes known simply as pyrrolidones, [1] are a class of drugs that share a pyrrolidone nucleus. [2] [3] [4] Many, but not all, specifically have a 2-oxo-1-pyrrolidine acetamide nucleus. Some racetams, such as piracetam, aniracetam, oxiracetam, pramiracetam, and phenylpiracetam, are considered ...
Racetams, such as piracetam, oxiracetam, phenylpiracetam, and aniracetam, are often marketed as cognitive enhancers and sold over the counter. [ 24 ] [ 25 ] A 2019 study found that piracetam supplements sold in the United States were inaccurately labeled. [ 25 ]
Racetams, such as piracetam, oxiracetam, phenylpiracetam, and aniracetam, are often marketed as cognitive enhancers and sold over the counter. [ 2 ] [ 17 ] A 2019 study found that piracetam supplements sold in the United States were inaccurately labeled. [ 17 ]
Phenylpiracetam, also known as 4-phenylpiracetam, is a racetam (i.e., a 2-oxo-1-pyrrolidine acetamide derivative) and the 4-phenyl-substituted analogue of piracetam. [ 2 ] [ 8 ] In contrast to piracetam and most other racetams however, phenylpiracetam contains β-phenylethylamine within its chemical structure and hence can additionally be ...
N-Phenylacetyl-l-prolylglycine ethyl ester is promoted as a nootropic and is a prodrug of cyclic glycine-proline. [a] [2] Other names include the brand name Noopept (Russian: Ноопепт), developmental code GVS-111, and proposed INN omberacetam.
Mounjaro vs. Ozempic: Which Is Better for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. They’re both once-a-week injectable drugs designed to help patients with ...
Phenylpiracetam hydrazide, also known as fonturacetam hydrazide, [1] is a racetam that is a derivative of phenylpiracetam in which the amide group is replaced with a hydrazide group. It was first reported by a Russian research group in 1980 as part of a series of chemical compounds investigated as anticonvulsants. [2]